Take a closer look at GE, Philips and Siemens Healthcare 2016 Performance Report (with data)
At the beginning of the year, major multinational companies announced their previous year's operating results, bringing a fine meal for the management and investment community. In the fiscal year of Siemens, from October 1, 2015 to September 30, 2016, their 2016 annual report was announced as early as November 2016; GE announced its 2016 results at the end of January 2017, and Philips also in 2017. In February, its 2016 results were announced. So, what is their performance as the most influential Big Three GPS in the medical field? How will the performance and business changes affect the industry? Please listen to the author. If there are any errors or omissions, welcome to make a brick, thank you!
Income and profit
As can be seen from the table below, compared with the downturn in 2015, the three companies performed very well in 2016, both achieving double growth in sales revenue and net profit. Philips' overall growth is slightly lower than 2.7%, but if the lighting business to be sold is removed, its growth rate will be around 5%.
In terms of total operating income of the group, GE is the first, Siemens is the second, and Philips is the smallest; in the medical field, they are the same size, Philips is the largest, GE is the second, and Siemens is the smallest.
From the perspective of the medical business sector, Philips has a higher proportion of the sector with a 100% focus on the long-term strategy of the medical business; while Siemens and GE account for a relatively low proportion, between 15-17%.
Table 1: GPS revenue and profit comparison (GE units are million dollars; the other two are millions of euros)
Subregional performance
From a regional perspective, with the slow recovery of the overall US and European economies, the Big Three have achieved growth in these regional markets. The growth rate of the developing countries is good, and it is the source of power for the growth of the Big Three.
In China's performance, GE has fully recovered its rapid growth momentum. Last year, Q4 reached a record-breaking 19%, and the average annual growth rate also reached a double-digit growth of 11%. Philips' performance in China is quite satisfactory, mainly because the lighting business is declining, and the medical business is growing well. Siemens' overall performance in China is poor, with only double-digit growth in energy and healthcare.
Table 2: Comparison of GPS area performance (GE units are millions of dollars; the other two are millions of euros)
Qingdao Beautiful Skin Biotechnology Co., Ltd , https://www.hafilleresthetic.com